Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment

Keyphrases

• Disease Treatment 100%
• Synapse 100%
• Adaptation 100%
• Signaling System 100%
• Disease Pathophysiology 100%
• Neuropsychiatric Diseases 100%
• Endocannabinoids 100%
• Obesity 50%
• Synaptic 50%
• Epilepsy 50%
• Excitability 50%
• Pathophysiology 50%
• Neurological Disorders 50%
• Lipids 50%
• Psychiatric Disorders 50%
• Substance Use Disorder 50%
• Targeted Therapeutics 50%
• Disease States 50%
• Physiological Processes 50%
• Pathological State 50%
• Ongoing Development 50%
• Spontaneous Excitatory Postsynaptic Current (sEPSC) 50%
• Neurotransmitter Release 50%
• Biobehavioral 50%
• Neuromodulators 50%
• Novel Treatments 50%
• Astrocytes 50%
• Stress Disorders 50%
• Developmental Disorders 50%
• Cellular Respiration 50%
• Link Adaptation 50%
• Disease Resilience 50%

Medicine and Dentistry

• Synapse 100%
• Pathophysiology 100%
• Endocannabinoid 100%
• Stress-Related Disorders 33%
• Developmental Disorder 33%
• Physiological Process 33%
• Excitability 33%
• Neurotransmitter Release 33%
• Cell Respiration 33%
• Mental Disorder 33%
• Nervous System Disorder 33%
• Substance Abuse 33%
• Astrocyte 33%
• Diseases 33%

Neuroscience

• Synapse 100%
• Endocannabinoid 100%
• Cellular Respiration 50%
• Stress-Related Disorders 50%
• Nervous System Disorder 50%
• Mental Disorder 50%
• Substance Abuse 50%
• Excitability 50%
• Neurotransmitter Release 50%
• Astrocyte 50%